Technology | January 21, 2014

HA85 PUR Relief is first FDA-registered skin care product for chemotherapy, radiation burns

American MD Labs HA85 PUR Relief Radiation Therapy

January 21, 2013 — American MD Labs’ HA85 PUR Relief skin care products are formulated to soothe symptoms related to chemotherapy and radiation treatment such as extremely dry skin, burns and muscle pain. 
 
HA85 PUR Relief contains hyaluronan, a naturally occurring polysaccharide that repairs skin tissues by embedding cells and fibrous constituents such as collagen and elastin. Hyaluronan binds 1,000 times its weight in water, which can contribute to skin tissue hydration. HA85 PUR Relief uses three different molecular weights of hyaluronan: 1 million daltons, 50,000 daltons and 5,000 daltons, which work on, under and deep under the surface of the skin, respectively. 
 
HA85 PUR Relief combines peptide technology with quaternary ammines to restore cellular membrane balance and treat radiation burns. HA85 PUR Relief’s key ingredients are designed to mimic the skin’s structure and auto-adjust pH to optimize production of enzymes that naturally heal wounds and promote skin homeostasis. 
 
Allantoin works as an anti-irritant and skin protectant, increases water content of the extracellular matrix and promotes cell replication. 
 
HA85 PUR Relief endeavors to provide deep hydration, relief and protection before, during and after treatment. The HA85 PUR Relief Professional Series will be available in both gel and spray applications and are water-free.
 
For more information: purrelief.com

Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now